Dr Freitag obtained his medical degree from Kiel University, Germany in 1994. He started his career in the pharmaceutical industry at Roche in pharmacovigilance and medical affairs. At Shire, he held several positions in clinical development and medical affairs, covering the internal medicine portfolio, finally as VP, Global Clinical development and Innovation. In 2014 he joined BTG plc in the UK as SVP to head up Vascular Medicine and moved on to become responsible for global clinical development across the portfolio. He joined Debiopharm International SA in 2016 to lead the clinical R&D function managing international drug development across Phase I to III. Recently, he joined Dynacure as Chief Medical Officer where he is responsible for medical and regulatory strategy, including clinical development of the lead compound in CNM.
PLEASE DONATECLICK HERE
NEWS & UPDATES
- Please join us for two Hope Walks in September, in Devon & IrelandAugust 14, 2019Every year the Myotubular Trust organises their own walking event called the ‘Hope Walk’ in London over a weekend in May. This year, we […]
- Four Cyclists ‘RideLondon 46’ in loving memory of OliverAugust 14, 2019On Sunday 4th August, four very close friends – Tomas, Charlie, Jonathan and Matthew – completed the RideLondon 46 in memory of Tomas’s son, […]
- Dynacure Receives Orphan Drug Designation from the US FDA for DYN101, an Antisense Medicine to Treat Rare Disease ‘Centronuclear Myopathies’August 8, 2019Company expects to initiate Phase 1 / 2 study ‘Unite-CNM’ in 2H2019 Today, August 8, 2019, Dynacure, a clinical stage drug development company […]
- London 10K 2019 – Smiles All Round From Our Fantastic Runners!August 7, 2019On July 21st the Westminster London 10k run took place, attracting over 30,000 runners of all abilities, amongst which were several wonderful […]
- Announcing the next European Family Conference in Frankfurt in May 2020July 22, 2019#TogetherEvenStronger2020 (PDF) Download Save The Date for the European MTM-CNM Family Conference 21-24 May 2020 […]